ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Organon & Co

Organon & Co (7XP)

11,595
0,07
(0,61%)
Fermé 07 Juin 10:00PM

Organon & Co (7XP) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
11,595
( 0,61% )
Prix Achat
11,53
Prix Vente
11,65
Volume échangé
3 905
11,54 Fourchette du Jour 11,60
4,973 Plage de 52 semaines 11,60
Cap du marché
Clôture Veille
11,525
Ouverture
11,54
Dernière Transaction
134
@
11.59
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
8 709 865 €
Actions en circulation
262 600 862
Rendement du Dividende (LTM)
0,08 (0,60%)
Ratio Cours sur Bénéfices
14,15
Bénéfice par action (BPA)
0,94
Chiffre d'affairess (LTM)
6,16B
Bénéfice net (LTM)
246M

À propos de Organon & Co

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comp... Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Jersey City, United States
Fondé
2026
Organon & Co est coté dans le secteur Healthcare de la Tradegate (DE) avec le ticker 7XP. Le dernier cours de clôture d'Organon & était de 11,53 €. Au cours de la dernière année, les actions de Organon & ont été négociées dans une fourchette de prix de 4,973 € à 11,60 €.

Organon & compte actuellement 262 600 862 actions en circulation. La capitalisation boursière d'Organon & est de 3,04 € milliard. Organon & a un ratio cours/bénéfice (ratio PE) de 14.15.

7XP Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.211.8445322793111.38511.611.34106411.47827223DE
40.21.7551557700711.39511.611.195331911.44757382DE
126.123111.8969298255.47211.64.97369009.57877037DE
265.37786.47475072376.21811.64.97356828.18040965DE
523.161000137.47925228228.433999911.64.97350767.65967101DE
156-7.115-38.027792624318.7121.564.973314910.33377274DE
260-17.345-59.934346924728.9436.7354.973211810.92538307DE

7XP - Frequently Asked Questions (FAQ)

What is the current Organon & Co share price?
The current share price of Organon & Co is 11,595 €
How many Organon & Co shares are in issue?
Organon & Co has 262 600 862 shares in issue
What is the market cap of Organon & Co?
The market capitalisation of Organon & Co is EUR 3,04B
What is the 1 year trading range for Organon & Co share price?
Organon & Co has traded in the range of 4,973 € to 11,60 € during the past year
What is the PE ratio of Organon & Co?
The price to earnings ratio of Organon & Co is 14,15
What is the cash to sales ratio of Organon & Co?
The cash to sales ratio of Organon & Co is 0,57
What is the registered address of Organon & Co?
The registered address for Organon & Co is 30 Hudson Street, Jersey City, New Jersey, 07302
What is the Organon & Co website address?
The website address for Organon & Co is www.organon.com
Which industry sector does Organon & Co operate in?
Organon & Co operates in the Pharmaceuticals sector

7XP Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock